Citius Pharmaceuticals Inc (CTXR)

Dec 11, 2025

Citius Oncology closes $18 million in offerings to support LYMPHIR launch - Investing.com Nigeria

Dec 11, 2025

Dec 10, 2025

Citius Oncology closes $18 million in offerings to support LYMPHIR launch By Investing.com - Investing.com South Africa

Dec 10, 2025

Dec 10, 2025

Citius Oncology Announces Closing of $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules - Benzinga

Dec 10, 2025

Dec 09, 2025

Citius Oncology shares sink after announcing $18M fundraising deal - MSN

Dec 09, 2025

Dec 09, 2025

Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules - PR Newswire

Dec 09, 2025

Dec 07, 2025

Aug Selloffs: Is Citius Pharmaceuticals Inc stock positioned for digital transformationPortfolio Gains Summary & Free Real-Time Volume Trigger Notifications - moha.gov.vn

Dec 07, 2025

Dec 05, 2025

Is Citius Pharmaceuticals Inc. (47N0) stock good for wealth creationJuly 2025 Momentum & Safe Investment Capital Preservation Plans - Newser

Dec 05, 2025

Dec 04, 2025

How Citius Pharmaceuticals Inc. (47N0) stock reacts to fiscal policiesJuly 2025 Big Picture & Trade Opportunity Analysis - Newser

Dec 04, 2025

Dec 04, 2025

CTXR: Analyst Jason Kolbert Maintains 'Buy' Rating with $6 Price Target | CTXR Stock News - GuruFocus

Dec 04, 2025

Dec 04, 2025

Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim - The Malaysian Reserve

Dec 04, 2025

Dec 04, 2025

Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Midd - GuruFocus

Dec 04, 2025

Dec 04, 2025

How supply shortages influence Citius Pharmaceuticals Inc. (47N0) stockWeekly Market Outlook & AI Powered Trade Plan Recommendations - Newser

Dec 04, 2025

Dec 04, 2025

How Citius Pharmaceuticals Inc. (47N0) stock responds to bond market2025 Investor Takeaways & AI Enhanced Trading Signals - Newser

Dec 04, 2025

Dec 03, 2025

Cutaneous T-cell Lymphoma Market Expected to Experience Major Growth by 2032, According to DelveInsight | Innate Pharma, Galderma R&D, Kyowa Kirin, Citius Pharma, Soligenix, 4SC AG, oligenix, Ligand - Barchart.com

Dec 03, 2025

Dec 03, 2025

Citius Oncology launches Lymphir treatment for rare lymphoma - NJBIZ

Dec 03, 2025

Dec 03, 2025

How Citius Pharmaceuticals Inc. (47N0) stock reacts to new regulations2025 Analyst Calls & Momentum Based Trading Signals - Newser

Dec 03, 2025

Dec 03, 2025

Is Citius Pharmaceuticals Inc. (47N0) stock vulnerable to rate hikesDollar Strength & Capital Efficiency Focused Ideas - Newser

Dec 03, 2025

Dec 02, 2025

Citius Oncology enters distribution services agreement with Cardinal Health - MSN

Dec 02, 2025

Dec 02, 2025

Why Citius Pharmaceuticals Inc. (47N0) stock is a must watch tickerWeekly Loss Report & Reliable Entry Point Trade Alerts - Newser

Dec 02, 2025

Dec 02, 2025

Citius Oncology Launches LYMPHIR, The First CTCL Systemic Therapy In Over 7 Years - Nasdaq

Dec 02, 2025

Dec 02, 2025

Citius Pharmaceuticals Launches LYMPHIR for T-Cell Lymphoma - MSN

Dec 02, 2025

Dec 02, 2025

Will Citius Pharmaceuticals Inc. (47N0) stock boost dividends furtherProduct Launch & Stepwise Trade Signal Implementation - Newser

Dec 02, 2025

Dec 02, 2025

How Citius Pharmaceuticals Inc. (47N0) stock moves in volatile trading sessions - Newser

Dec 02, 2025

Dec 02, 2025

Citius Oncology Announces U.S. Commercial Launch of LYMPHIRtm, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL) - Lelezard

Dec 02, 2025

Dec 02, 2025

CTORCitius Oncology, Inc. Latest Stock News & Market Updates - Stock Titan

Dec 02, 2025

Dec 01, 2025

Citius Pharmaceuticals, Inc. Launches LYMPHIR for CTCL Treatment - TradingView

Dec 01, 2025

Dec 01, 2025

Citius Oncology Announces U.S. Commercial Launch of LYMPHIR, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL) - Finviz

Dec 01, 2025

Dec 01, 2025

Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL) – Company AnnouncementFT.com - Financial Times

Dec 01, 2025

Dec 01, 2025

Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL) - Sahm

Dec 01, 2025

Nov 28, 2025

Why Citius Pharmaceuticals Inc. stock remains resilientIPO Watch & AI Forecasted Entry/Exit Points - BỘ NỘI VỤ

Nov 28, 2025

Nov 26, 2025

Citius Oncology Deploys AI Platform to Amplify the Performance of its Commercial Team Ahead of LYMPHIR Launch - Aktiellt

Nov 26, 2025

Nov 25, 2025

Citius Oncology to Exhibit at the 67th American Society of Hematology (ASH) Annual Meeting - 富途牛牛

Nov 25, 2025

Nov 23, 2025

Butterfly Network, Citius Pharma Drive Biotech Momentum In After-Hours Trading - Nasdaq

Nov 23, 2025

Nov 21, 2025

Citius Oncology to advance LYMPHIR launch with AI technology By Investing.com - Investing.com Nigeria

Nov 21, 2025

Nov 21, 2025

Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration - Placera.se

Nov 21, 2025

Nov 21, 2025

Citius Oncology stock soars on expanded AI collaboration for LYMPHIR launch - Investing.com

Nov 21, 2025

Nov 21, 2025

Citius Oncology to advance LYMPHIR launch with AI technology - Investing.com India

Nov 21, 2025

Nov 21, 2025

Citius Oncology (Nasdaq: CTOR) taps Verix AI to support Q4 2025 LYMPHIR CTCL launch - Stock Titan

Nov 21, 2025

Nov 21, 2025

Can Citius Pharmaceuticals Inc. (47N0) stock sustain free cash flow - newser.com

Nov 21, 2025

Nov 21, 2025

How Citius Pharmaceuticals Inc. stock reacts to Fed rate cutsStop Loss & Weekly High Potential Stock Alerts - newser.com

Nov 21, 2025

Nov 20, 2025

Can Citius Pharmaceuticals Inc. (47N0) stock withstand sector downturns2025 Top Decliners & Long-Term Safe Investment Plans - newser.com

Nov 20, 2025

Nov 20, 2025

Is Citius Pharmaceuticals Inc. (47N0) stock good for long term investingMarket Activity Summary & Daily Entry Point Trade Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

Visual analytics tools that track Citius Pharmaceuticals Inc. performanceJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com

Nov 19, 2025